314 related articles for article (PubMed ID: 19072826)
1. Hematopoietically expressed homeobox is a target gene of farnesoid X receptor in chenodeoxycholic acid-induced liver hypertrophy.
Xing X; Burgermeister E; Geisler F; Einwächter H; Fan L; Hiber M; Rauser S; Walch A; Röcken C; Ebeling M; Wright MB; Schmid RM; Ebert MP
Hepatology; 2009 Mar; 49(3):979-88. PubMed ID: 19072826
[TBL] [Abstract][Full Text] [Related]
2. Bile acids induce the expression of the human peroxisome proliferator-activated receptor alpha gene via activation of the farnesoid X receptor.
Pineda Torra I; Claudel T; Duval C; Kosykh V; Fruchart JC; Staels B
Mol Endocrinol; 2003 Feb; 17(2):259-72. PubMed ID: 12554753
[TBL] [Abstract][Full Text] [Related]
3. Farnesoid X receptor activation by chenodeoxycholic acid induces detoxifying enzymes through AMP-activated protein kinase and extracellular signal-regulated kinase 1/2-mediated phosphorylation of CCAAT/enhancer binding protein β.
Noh K; Kim YM; Kim YW; Kim SG
Drug Metab Dispos; 2011 Aug; 39(8):1451-9. PubMed ID: 21596890
[TBL] [Abstract][Full Text] [Related]
4. The farnesoid X receptor induces very low density lipoprotein receptor gene expression.
Sirvent A; Claudel T; Martin G; Brozek J; Kosykh V; Darteil R; Hum DW; Fruchart JC; Staels B
FEBS Lett; 2004 May; 566(1-3):173-7. PubMed ID: 15147890
[TBL] [Abstract][Full Text] [Related]
5. Regulation of human liver delta-aminolevulinic acid synthase by bile acids.
Peyer AK; Jung D; Beer M; Gnerre C; Keogh A; Stroka D; Zavolan M; Meyer UA
Hepatology; 2007 Dec; 46(6):1960-70. PubMed ID: 17975826
[TBL] [Abstract][Full Text] [Related]
6. Bile acid signaling through FXR induces intracellular adhesion molecule-1 expression in mouse liver and human hepatocytes.
Qin P; Borges-Marcucci LA; Evans MJ; Harnish DC
Am J Physiol Gastrointest Liver Physiol; 2005 Aug; 289(2):G267-73. PubMed ID: 15817812
[TBL] [Abstract][Full Text] [Related]
7. Role of nuclear receptors and hepatocyte-enriched transcription factors for Ntcp repression in biliary obstruction in mouse liver.
Zollner G; Wagner M; Fickert P; Geier A; Fuchsbichler A; Silbert D; Gumhold J; Zatloukal K; Kaser A; Tilg H; Denk H; Trauner M
Am J Physiol Gastrointest Liver Physiol; 2005 Nov; 289(5):G798-805. PubMed ID: 16002565
[TBL] [Abstract][Full Text] [Related]
8. Farnesoid X receptor protects human and murine gastric epithelial cells against inflammation-induced damage.
Lian F; Xing X; Yuan G; Schäfer C; Rauser S; Walch A; Röcken C; Ebeling M; Wright MB; Schmid RM; Ebert MP; Burgermeister E
Biochem J; 2011 Sep; 438(2):315-23. PubMed ID: 21619550
[TBL] [Abstract][Full Text] [Related]
9. The farnesoid X receptor induces fetuin-B gene expression in human hepatocytes.
Murakami T; Walczak R; Caron S; Duhem C; Vidal V; Darteil R; Staels B
Biochem J; 2007 Nov; 407(3):461-9. PubMed ID: 17655523
[TBL] [Abstract][Full Text] [Related]
10. Regulation of the human bile acid UDP-glucuronosyltransferase 1A3 by the farnesoid X receptor and bile acids.
Erichsen TJ; Aehlen A; Ehmer U; Kalthoff S; Manns MP; Strassburg CP
J Hepatol; 2010 Apr; 52(4):570-8. PubMed ID: 20189675
[TBL] [Abstract][Full Text] [Related]
11. The nuclear hormone receptor farnesoid X receptor (FXR) is activated by androsterone.
Wang S; Lai K; Moy FJ; Bhat A; Hartman HB; Evans MJ
Endocrinology; 2006 Sep; 147(9):4025-33. PubMed ID: 16675527
[TBL] [Abstract][Full Text] [Related]
12. VPAC1 expression is regulated by FXR agonists in the human gallbladder epithelium.
Chignard N; Mergey M; Barbu V; Finzi L; Tiret E; Paul A; Housset C
Hepatology; 2005 Sep; 42(3):549-57. PubMed ID: 16037943
[TBL] [Abstract][Full Text] [Related]
13. Upregulation of a basolateral FXR-dependent bile acid efflux transporter OSTalpha-OSTbeta in cholestasis in humans and rodents.
Boyer JL; Trauner M; Mennone A; Soroka CJ; Cai SY; Moustafa T; Zollner G; Lee JY; Ballatori N
Am J Physiol Gastrointest Liver Physiol; 2006 Jun; 290(6):G1124-30. PubMed ID: 16423920
[TBL] [Abstract][Full Text] [Related]
14. The bile acid sensor farnesoid X receptor is a modulator of liver immunity in a rodent model of acute hepatitis.
Mencarelli A; Renga B; Migliorati M; Cipriani S; Distrutti E; Santucci L; Fiorucci S
J Immunol; 2009 Nov; 183(10):6657-66. PubMed ID: 19880446
[TBL] [Abstract][Full Text] [Related]
15. Chenodeoxycholic acid-mediated activation of the farnesoid X receptor negatively regulates hydroxysteroid sulfotransferase.
Miyata M; Matsuda Y; Tsuchiya H; Kitada H; Akase T; Shimada M; Nagata K; Gonzalez FJ; Yamazoe Y
Drug Metab Pharmacokinet; 2006 Aug; 21(4):315-23. PubMed ID: 16946559
[TBL] [Abstract][Full Text] [Related]
16. Spontaneous development of liver tumors in the absence of the bile acid receptor farnesoid X receptor.
Yang F; Huang X; Yi T; Yen Y; Moore DD; Huang W
Cancer Res; 2007 Feb; 67(3):863-7. PubMed ID: 17283114
[TBL] [Abstract][Full Text] [Related]
17. Farnesoid X receptor up-regulates expression of lipid transfer inhibitor protein in liver cells and mice.
Li L; Liu H; Peng J; Wang Y; Zhang Y; Dong J; Liu X; Guo D; Jiang Y
Biochem Biophys Res Commun; 2013 Nov; 441(4):880-5. PubMed ID: 24211198
[TBL] [Abstract][Full Text] [Related]
18. Oxysterol 22(R)-hydroxycholesterol induces the expression of the bile salt export pump through nuclear receptor farsenoid X receptor but not liver X receptor.
Deng R; Yang D; Yang J; Yan B
J Pharmacol Exp Ther; 2006 Apr; 317(1):317-25. PubMed ID: 16371446
[TBL] [Abstract][Full Text] [Related]
19. The hepatic orosomucoid/α1-acid glycoprotein gene cluster is regulated by the nuclear bile acid receptor FXR.
Porez G; Gross B; Prawitt J; Gheeraert C; Berrabah W; Alexandre J; Staels B; Lefebvre P
Endocrinology; 2013 Oct; 154(10):3690-701. PubMed ID: 23861371
[TBL] [Abstract][Full Text] [Related]
20. Bile acids reduce SR-BI expression in hepatocytes by a pathway involving FXR/RXR, SHP, and LRH-1.
Malerød L; Sporstøl M; Juvet LK; Mousavi SA; Gjøen T; Berg T; Roos N; Eskild W
Biochem Biophys Res Commun; 2005 Nov; 336(4):1096-105. PubMed ID: 16168958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
